2026 NPPES data Oncology Pharmacist NPI 1164596599 PHARMD
Verify on CMS →

LINDA NAMBA-GARCIA, PHARMD

Oncology Pharmacist in STOCKTON, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 188 beneficiaries · Oncology Pharmacist avg: 160
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

LINDA NAMBA-GARCIA, PHARMD filed 1,044 Medicare Part D claims in 2023 as a Oncology Pharmacist in STOCKTON, California, prescribing 73% generic.

1K
Part D claims, 2023
73%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LINDA NAMBA-GARCIA, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,044 Top 24% higher than 76% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about LINDA NAMBA-GARCIA, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 11/18/2006

NPI 1164596599

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

1,044 553% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in California

How Oncology Pharmacist compares to other specialties among California providers

California providers

Oncology Pharmacist share within California

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LINDA NAMBA-GARCIA, PHARMD appears in the CMS NPPES registry as a Oncology Pharmacist provider holding PHARMD credentials at 7373 WEST LN, STOCKTON, CA, 95210, with a listed phone of (209) 476-5478. NPI 1164596599 was issued on 11/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NAMBA-GARCIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,044 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $145K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7373 WEST LN
STOCKTON, CA 95210

Provider Details

NPI 1164596599
Specialty Oncology Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 11/18/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LINDA NAMBA-GARCIA, PHARMD. To verify LINDA NAMBA-GARCIA, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

LINDA NAMBA-GARCIA, PHARMD — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 1,044 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,044
Total Claims
$145K
Total Drug Cost
188
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,243
Total Day Supply
97,272
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$130K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.23
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LINDA NAMBA-GARCIA, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
114
Metformin Hcl Er
Metformin Hcl
110
Glipizide Er
Glipizide
106
Metformin Hcl
82
Glipizide
58
Humulin N
Insulin Nph Human Isophane
48
Jardiance
Empagliflozin
46
Humulin N Kwikpen
Insulin Nph Human Isophane
36
Amlodipine Besylate
27
Losartan Potassium
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Pharmacist Overview

How LINDA NAMBA-GARCIA, PHARMD fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

LINDA NAMBA-GARCIA, PHARMD's 1,044 claims are above the specialty average of 160.

Nearby Oncology Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as NAMBA-GARCIA.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is LINDA NAMBA-GARCIA, PHARMD's specialty?
LINDA NAMBA-GARCIA, PHARMD specializes in Oncology Pharmacist and practices in STOCKTON, California. Credentials: PHARMD.
How much does LINDA NAMBA-GARCIA, PHARMD prescribe under Medicare Part D?
In 2023, LINDA NAMBA-GARCIA, PHARMD wrote 1,044 Medicare Part D claims totaling $145K in drug costs for 188 beneficiaries.
Where is LINDA NAMBA-GARCIA, PHARMD located?
LINDA NAMBA-GARCIA, PHARMD is located at 7373 WEST LN, STOCKTON, CA, 95210. Phone: (209) 476-5478.
What is LINDA NAMBA-GARCIA, PHARMD's NPI number?
LINDA NAMBA-GARCIA, PHARMD's National Provider Identifier (NPI) is 1164596599, issued on 11/18/2006.
Does LINDA NAMBA-GARCIA, PHARMD prescribe more brand-name or generic drugs?
LINDA NAMBA-GARCIA, PHARMD's prescribing is 27% brand-name and 73% generic drugs by claim count, with $130K in brand drug costs.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
What drugs does LINDA NAMBA-GARCIA, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, LINDA NAMBA-GARCIA, PHARMD's most frequently prescribed drugs include Atorvastatin Calcium, Metformin Hcl Er, Glipizide Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LINDA NAMBA-GARCIA, PHARMD accept Medicare?
LINDA NAMBA-GARCIA, PHARMD appears in CMS Medicare data with 1,044 Part D claims and 188 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LINDA NAMBA-GARCIA, PHARMD's credentials?
LINDA NAMBA-GARCIA, PHARMD's NPI is 1164596599 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology